Avails Medical Signs First Commercial Customer for Rapid AST System
The eQUANT System delivers antibiotic susceptibility testing results in 70 minutes, cutting turnaround time by up to 24 hours.
Read More
Search Results for: liver disease
Alveo Technologies Completes Expanded CDC Agreement for Seasonal and Avian Influenza Test
The company’s be.well platform can detect seasonal influenza A and B as well as avian influenza A(H5) in humans within 45 minutes at the point of care.
Read More
Tempus Acquires AI Pathology Company to Expand Diagnostic Capabilities
The acquisition strengthens Tempus’ multimodal platform with advanced AI-powered pathology solutions for clinical laboratories and healthcare providers.
Read More
FDA Grants Breakthrough Device Designation for Quest’s Haystack MRD Test
The circulating tumor DNA test is designed to identify MRD-positive patients with stage II colorectal cancer who may benefit from adjuvant therapy.
Read More
Quanterix Accelerator Laboratory Gains New York State Clinical Lab Permit
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
Read More